The biology and the role of biomarkers in SCLC – LUNGevity Foundation
LUNGevity Foundation shared a post on X:
”Join us for a Facebook Live on 11/1 as Triparna Sen discusses the biology and the role of biomarkers in SCLC.
Moderated by Misty Dawn Shields, Small Cell SMASHERS, Indiana University Health, and LUNGevity’s Ann Steagall. Tune in to join the conversation.”
Triparna Sen shared a post by LUNGevity Foundation, on X, adding:
”Thrilled to participate in the Small Cell SMASHERS Facebook Live with Misty Dawn Shields and Ann Steagall and discuss my favorite topic – small cell lung cancer!
Unlike a few years ago, the research and treatment landscape of Small Cell Lung Cancer (SCLC) is fast evolving and progressing.
So join us on November 1 as we discuss – evolving biology, promising biomarkers, recent FDA approval, exciting new targets/treatment strategies, clinical trials.
Tune in to join the conversation.”
Triparna Sen is an Associate Professor, in the Department of Oncological Sciences, and the Director of the Lung Cancer PDX Platform at the Icahn School of Medicine at Mount Sinai, New York. She leads a multi-disciplinary team of investigators in laboratory-based, patient-focused investigations focused on cancer biology and precision medicine.
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023